Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $85M
Founded date: 2018
Investors 5
| Date | Name | Website |
| 25.08.2026 | Alta Partn... | altapartne... |
| - | DC Investm... | dcinvestme... |
| - | Frazier Li... | frazierls.... |
| 10.01.2024 | Longitude ... | longitudec... |
| - | Catalio Ca... | cataliocap... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.12.2023 | Series B | $85M | - |
Mentions in press and media 2
| Date | Title | Description |
| 20.12.2023 | Lassen Therapeutics Closes $85M Series B Financing | Lassen Therapeutics, a San Diego, CA-based clinical stage biotech company, raised $85M in Series B funding. The round was led by Frazier Life Sciences with participation from Longitude Capital. The syndicate also included new investors BVF ... |
| - | Lassen Therapeutics | “Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.” |